Recombinant DNA -- Experiments -- Quality control. : The planned release of live organisms modified by recombinant DNA techniques : points to consider in the preparation of proposals for genetic assessment by the Committee / Recombinant DNA Monitoring Committee
Recombinant DNA -- Law and legislation. : Monitoring recombinant DNA technology : a five year review / Department of Industry, Technology and Commerce, Recombinant DNA Monitoring Committee
Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected
Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers